Log in

Relevant bibliographies by topics / Kaposi's sarcoma / Journal articles

To see the other types of publications on this topic, follow the link: Kaposi's sarcoma.

Journal articles on the topic 'Kaposi's sarcoma'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 August 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Kaposi's sarcoma.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Santos, Mônica, Virginia Vilasboas, Luciana Mendes, Carolina Talhari, and Sinésio Talhari. "Lymphangiectatic Kaposi's sarcoma in a patient with AIDS." Anais Brasileiros de Dermatologia 88, no. 2 (April 2013): 276–78. http://dx.doi.org/10.1590/s0365-05962013000200019.

Full text

Abstract:

Kaposi's sarcoma is a malignant disease that originates in the lymphatic endothelium. It has a broad spectrum of clinical manifestations. Its four distinct clinical forms are: classic, endemic, iatrogenic and epidemic Kaposi's sarcoma. In non-HIV-associated Kaposi's sarcoma, the disease is typically limited to the lower extremities, but in immunodeficient patients, it is a multifocal systemic disease. The clinical course of the disease differs among patients, ranging from a single or a few indolent lesions to an aggressive diffuse disease. Advanced Kaposi's sarcoma lesions, typically those on the lower extremities, are often associated with lymphedema. In this paper, we report a case of a patient with a rare form of AIDS-associated Kaposi sarcoma called lymphangiectatic Kaposis's sarcoma.

APA, Harvard, Vancouver, ISO, and other styles

2

Bushati, Teona, Leart Berdica, Albina Ndoja, Erion Sukaj, Ilirian Ibrushi, and Leon Kaza. "Scrotal Kaposi's Sarcoma in HIV-negative Patient: A Case Report and Review of the Literature." Albanian Journal of Trauma and Emergency Surgery 7, no. 2 (July 20, 2023): 1304–7. http://dx.doi.org/10.32391/ajtes.v7i2.260.

Full text

Abstract:

Background: Kaposi's sarcoma (KS) is an indolent angio-proliferative tumor proliferation with spindle cells originating from endothelial and immune cells infected with human herpes virus type 8. (HHV-8: also known as Kaposi sarcoma herpes virus [KSHV]). HHV-8 was identified as the causative agent of KS. This virus is present in 95-98% of cases with KS. Kaposi's sarcoma was first described by a Hungarian dermatologist 1872 named Moritz Kaposi.[1] The lesions are characterized by the proliferation of spindle cells of endothelial origin, which present different degrees of abnormal vascularization, inflammatory infiltrates, and fibrosis. Kaposi's Sarcoma (KS) is a malignancy that generally affects the skin, and can be systemic with internal organ involvement. It originates from the vascular endothelium. KS's relationship with human immunodeficiency virus (HIV) infection is well known. In this article, we will present a 73-year-old male patient with 3 purple scrotal lesions up to 0.5 cm in size. Conclusion; Kaposi's sarcoma of the scrotum in a negative patient is a rare pathology. However, in cases of scrotal lesions that last over time, a differential diagnosis should be made and Kaposi's sarcoma should be taken into consideration. Also, a screening for other accompanying lesions, especially a detailed examination of the gastrointestinal tract is important in cases of Kaposi’s sarcoma of the scrotum.

APA, Harvard, Vancouver, ISO, and other styles

3

Dertlioğlu, Selma Bakar. "Kaposi Sarcoma of the Lower Extremity with HIV and Kaposi's Sarcoma." Journal of Clinical Case Reports and Studies 2, no. 1 (July 1, 2021): 01–03. http://dx.doi.org/10.31579/2690-8808/059.

Full text

Abstract:

Kaposi's sarcoma is the most common malignancy seen with HIV infection. It is a lymphoangioproliferous tumor first described by Moritz Kaposi in 1872. It is characterized by bluish red or dark brown plaques and nodules, especially in the distal of the lower extremities, often the heels and feet. Organ involvement without skin findings is observed in approximately 15% of the cases. There are four clinical variants, the classical, endemic, iatrogenic and the epidemic associated with AIDS. Kaposi's sarcoma in AIDS cases apart from the skin, it can also be seen in the oral cavity, gastro-intestinal system and respiratory system. Antiretroviral therapy (ART) should be started immediately in newly diagnosed HIV infected patients. In this research, a 65 year old male patient, who was diagnosed AIDS and Kaposi's sarcoma at the same time, is described.

APA, Harvard, Vancouver, ISO, and other styles

4

Merimsky, Ofer, and Samario Chaitchik. "Kaposi's Sarcoma on a Lymphedematous Arm following Radical Mastectomy." Tumori Journal 78, no. 6 (December 1992): 407–8. http://dx.doi.org/10.1177/030089169207800614.

Full text

Abstract:

Chronic lymphedema predisposes for local Immune incompetence, manifested by development of Stuart-Treves syndrome, Kaposi's sarcoma and fibroma-like lesions. A 91-year-old female with multiple cancers developed classic Kaposi's sarcoma on a chronically lymphedematous arm 26 years after radical mastectomy and irradiation of the involved axilla. The Kaposi lesion partially responded to electron beam irradiation.

APA, Harvard, Vancouver, ISO, and other styles

5

Ellis, Harold. "Moritz (Maurice) Kaposi: Kaposi's Sarcoma." Journal of Perioperative Practice 23, no. 9 (September 2013): 208. http://dx.doi.org/10.1177/175045891302300906.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Gruffat, Henri, Alain Sergeant, and Evelyne Manet. "Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma." Microbes and Infection 2, no. 6 (May 2000): 671–80. http://dx.doi.org/10.1016/s1286-4579(00)00358-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

DiAlberti, L., G. G. Teo, S. Porter, J. Zakrzewska, and C. Scully. "Kaposi's sarcoma herpesvirus in oral kaposi's sarcoma." European Journal of Cancer Part B: Oral Oncology 32, no. 1 (January 1996): 68–69. http://dx.doi.org/10.1016/0964-1955(96)00003-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Ognibene, Frederick P., and James H. Shelhamer. "Kaposi's Sarcoma." Clinics in Chest Medicine 9, no. 3 (September 1988): 459–65. http://dx.doi.org/10.1016/s0272-5231(21)00523-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

James, D. Geraint. "Kaposi's sarcoma." Journal of Medical Biography 19, no. 1 (February 2011): 14. http://dx.doi.org/10.1258/jmb.2009.009084.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Antman, Karen, and Yuan Chang. "Kaposi's Sarcoma." New England Journal of Medicine 342, no. 14 (April 6, 2000): 1027–38. http://dx.doi.org/10.1056/nejm200004063421407.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Dalgleish, AG. "Kaposi's sarcoma." British Journal of Cancer 64, no. 1 (July 1991): 3–6. http://dx.doi.org/10.1038/bjc.1991.229.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Pantanowitz, Liron, and Bruce J. Dezube. "Kaposi's Sarcoma." Ear, Nose & Throat Journal 83, no. 3 (March 2004): 157. http://dx.doi.org/10.1177/014556130408300307.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Naidich, David P., Mark Tarras, Stuart M. Garay, Bernard Birnbaum, Benito J. Rybak, and Roger Schinella. "Kaposi's Sarcoma." Chest 96, no. 4 (October 1989): 723–28. http://dx.doi.org/10.1378/chest.96.4.723.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Krown, Susan E., Josephine Paredes, and Patricia L. Myskowski. "Kaposi'S Sarcoma." Medical Clinics of North America 76, no. 1 (January 1992): 235–52. http://dx.doi.org/10.1016/s0025-7125(16)30378-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Gascón, Pere, and Robert A. Schwartz. "KAPOSI'S SARCOMA." Dermatologic Clinics 18, no. 1 (January 2000): 169–75. http://dx.doi.org/10.1016/s0733-8635(05)70157-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

FINESMITH, TINA H., and JOSEPH P. SHRUM. "KAPOSI'S SARCOMA." International Journal of Dermatology 33, no. 11 (November 1994): 755–62. http://dx.doi.org/10.1111/j.1365-4362.1994.tb00983.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Flore, Ornella. "Kaposi's sarcoma." Lancet 364, no. 9436 (August 2004): 740–41. http://dx.doi.org/10.1016/s0140-6736(04)16952-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Sanders, Cornelus JG, Marijke R. Canninga-van Dijk, and Jan C. Borleffs. "Kaposi's sarcoma." Lancet 364, no. 9444 (October 2004): 1549–52. http://dx.doi.org/10.1016/s0140-6736(04)17280-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Stickler, Mitchell C., and Alvin E. Friedman-Kien. "Kaposi's sarcoma." Clinics in Dermatology 9, no. 1 (January 1991): 39–47. http://dx.doi.org/10.1016/0738-081x(91)90113-y.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Tappero, Jordan W., Marcus A. Conant, Steven F. Wolfe, and Timothy G. Berger. "Kaposi's sarcoma." Journal of the American Academy of Dermatology 28, no. 3 (March 1993): 371–95. http://dx.doi.org/10.1016/0190-9622(93)70057-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Dictor, Michael. "Kaposi's sarcoma." Virchows Archiv A Pathological Anatomy and Histopathology 409, no. 1 (1986): 23–35. http://dx.doi.org/10.1007/bf00705404.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Myskowski, Patricia L. "Kaposi's Sarcoma." Archives of Dermatology 129, no. 10 (October 1, 1993): 1320. http://dx.doi.org/10.1001/archderm.1993.01680310090016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Flotte, Thomas. "Kaposi's Sarcoma." Archives of Dermatology 122, no. 1 (January 1, 1986): 108. http://dx.doi.org/10.1001/archderm.1986.01660130112041.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Delisle, Bernard R. "Kaposi's Sarcoma." Archives of Dermatology 126, no. 4 (April 1, 1990): 553. http://dx.doi.org/10.1001/archderm.1990.01670280139041.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Marshall, M. E. "Arteriovenous malformation simulating Kaposi's sarcoma (pseudo-Kaposi's sarcoma)." Archives of Dermatology 121, no. 1 (January 1, 1985): 99–101. http://dx.doi.org/10.1001/archderm.121.1.99.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Chang, Y. "Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group." Archives of Internal Medicine 156, no. 2 (January 22, 1996): 202–4. http://dx.doi.org/10.1001/archinte.156.2.202.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Grabovskaya, Olga V., Natalia P. Teplyuk, Sergey A. Mishin, Ekaterina V. Grekova, Ekaterina R. Dunaeva, Alina V. Perekhodova, and Lidia M. Shnakhova. "Kaposi's sarcoma: Problems of differential diagnosis." Russian Journal of Skin and Venereal Diseases 26, no. 5 (November 17, 2023): 487–95. http://dx.doi.org/10.17816/dv492311.

Full text

Abstract:

Kaposi's sarcoma is a multifocal malignant disease of vascular origin with a primary lesion of the skin, as well as internal organs and lymph nodes. According to various authors, it is believed that Kaposi's sarcoma is associated with herpes simplex virus type 8 (HHV-8). According to the literature, the following types of Kaposi's sarcoma are distinguished: classical (European), immunosuppressive, endemic (African) and epidemic (this form of sarcoma is associated with the state of acquired immunodeficiency). Clinically, with Kaposi's sarcoma, rashes can vary depending on the form of the disease, among which there are spotty, papular and tumor forms. Also in the literature, some authors distinguish the 4th form of Kaposi's sarcoma ― bullous. Diagnostic search for Kaposi's sarcoma is a difficult problem due to the large number of diseases of vascular origin, as well as their clinical similarity. The diagnostic methods described in the literature include many studies, including a blood test for HHV-8, as well as routine histological examination and immunohistochemistry. The article presents a rare clinical case of Kaposi's sarcoma in a young girl with a long history of the disease.

APA, Harvard, Vancouver, ISO, and other styles

28

Steinfeld, AD, and JS Cooper. "Epidemic and classic Kaposi's sarcoma of the feet. A comparative study." Journal of the American Podiatric Medical Association 80, no. 9 (September 1, 1990): 469–70. http://dx.doi.org/10.7547/87507315-80-9-469.

Full text

Abstract:

The clinical behavior of Kaposi's sarcoma involving the feet is compared for patients with and without AIDS. Although AIDS-related Kaposi's sarcoma is less likely to be confined to the legs than is non-AIDS-related Kaposi's sarcoma, the legs are the most common site of disease in both forms. Kaposi's sarcoma occurring in the AIDS setting is as radiosensitive as that which occurs in the patient without AIDS. Palliative radiotherapy can offer substantial relief for affected patients.

APA, Harvard, Vancouver, ISO, and other styles

29

Boschoff, Chris, Denise Whitby, Theodora Hatziionnou, Cyril Fisher, Jon van der Walt, Angelos Hatzakis, Robin Weiss, and Thomas Schulz. "Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma." Lancet 345, no. 8956 (April 1995): 1043–44. http://dx.doi.org/10.1016/s0140-6736(95)90780-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Chang, Yuan. "Kaposi's Sarcoma-Associated Herpesvirus and Kaposi's Sarcoma in Africa." Archives of Internal Medicine 156, no. 2 (January 22, 1996): 202. http://dx.doi.org/10.1001/archinte.1996.00440020112014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Rajaratnam, K., and S. Desai. "Kaposi's sarcoma of the trachea." Journal of Laryngology & Otology 102, no. 10 (October 1988): 951–53. http://dx.doi.org/10.1017/s0022215100106905.

Full text

Abstract:

AbstractThe most common tracheal neoplasms are epidermoid carcinomas, papillomas and cylindromas. Kaposi's sarcoma, confined primarily to the trachea, is one of the rarest tumours. The clinical and histological picture of a case of Kaposi's sarcoma of the trachea in a young, pregnant woman, presenting with severe airway obstruction, is described here. The emergency tracheoscopy dislodged a mass from the trachea, which turned out to be a Kaposi's sarcoma on histology. Although Kaposi's sarcoma is one of the manifestations of AIDS, this patient had neither any underlying immunodeficiency nor any skin, visceral or lymphatic lesions.

APA, Harvard, Vancouver, ISO, and other styles

32

Trevisan, Flavia, Paulo Rowilson Cunha, Clovis Antonio Lopes Pinto, and Celia Antonia Xavier de Moraes Alves. "Classic Kaposi's sarcoma treated with elastic stockings and outpatient follow-up of a 90-year-old patient." Anais Brasileiros de Dermatologia 88, no. 6 suppl 1 (December 2013): 200–202. http://dx.doi.org/10.1590/abd1806-4841.20132104.

Full text

Abstract:

Kaposi's sarcoma is a multifactorial angioproliferative disorder. The herpes virus 8 human contributes to its pathogenesis, but it is uncertain whether these lesions are only reactive hyperplasia to the virus or neoplasia. Four clinical types are described: classic, endemic, iatrogenic and HIV-associated. Classic Kaposi's sarcoma has no standard staging or treatment protocols. Some studies have shown the use of compression stockings in the treatment of lymphedema associated with Kaposi's sarcoma. We report the case of a 90 year-old patient with classic Kaposi's sarcoma treated with compression stockings who showed a satisfactory response.

APA, Harvard, Vancouver, ISO, and other styles

33

Gervas, Reginald, and Edward Mgaya. "Histopathological patterns and topographical distribution of Kaposi Sarcoma at Muhimbili National Hospital, Tanzania." African Health Sciences 21, no. 4 (December 14, 2021): 1733–8. http://dx.doi.org/10.4314/ahs.v21i4.29.

Full text

Abstract:

Background: Kaposi sarcoma (KS) is derived from endothelial cell lineage; it is caused by Human Herpes Virus-8 (HHV-8) facilitated by immune suppression. KS remains one of the commonest sarcoma seen in Tanzania. The paucity of recent data makes monitoring the disease a challenge. This study describes the Histopathological Patterns and Topographical distribution of Kaposi Sarcoma at Muhimbili National Hospital, a tertiary care hospital in Tanzania. Methods: A hospital-based retrospective cross-sectional study was done to review biopsies sent to the Central Pathology Laboratory (CPL), Muhimbili National Hospital from 2010 to 2014. Results: A total of 818 cases representing 1.8 % of all malignancies during the study period were enrolled in the study. The age of patients at diagnosis ranged from 6 months to 94 years old, with the median age being 37 years. Male to female ratiowas 1.4:1.0. Females were younger than males (p < 0.001). The majority of the lesions were in the lower limbs, 352 (64.1%). Nodular KS accounted for 74.5% of all cases. Conclusion: Kaposi’s sarcoma remains a common malignancy. The patients present late at diagnosis. Early diagnosis and improved treatment protocols remain to be key steps towards reducing the burden of KS. Keywords: Kaposi's Sarcoma; Histopathological Patterns; Topographical distribution.

APA, Harvard, Vancouver, ISO, and other styles

34

Koyuncu, Ismail, Ataman Gönel, Emrah Ozcan, Ebru Temiz, Şahin Toprak, Feridun Akkafa, and Irfan Binici. "Single Nucleotide Polymorphism Analysis in HIV and Kaposi's Sarcoma Disease by Microarray Technique." Current HIV Research 18, no. 3 (June 12, 2020): 154–64. http://dx.doi.org/10.2174/1570162x18666200130100654.

Full text

Abstract:

Background: Emergence of Kaposi's Sarcoma in the cases other than HIV, following the use of immunosuppressant drugs, demonstrates that it is related to weak immunity. The fact that this malignancy does not occur in every HIV-positive patient suggests that genetic predisposition may also be effective. Replacement of one of the base pairs of adenine, guanine, cytosine, and thymine that constitute the DNA sequence in the human genome with another base pair can affect susceptibility to disease, response to treatment, and immunity. Objective: The purpose of this study is to analyze the Single Nucleotide Polymorphism that could predispose to Kaposi's sarcoma of an HIV-infected patient and to identify which nucleotides such SNPs correspond to, using the microarray technology. Material and Method: The blood samples of individuals, one of whom was diagnosed with Kaposi's Sarcoma HIV (+) visiting the outpatient clinic of infectious diseases polyclinic of Harran University Research and Practice Hospital and of a healthy individual with no Kaposi's Sarcoma, were used in the study. Following the DNA isolation of the blood samples taken from the respective individuals, a SNP analysis was conducted on the microarray device. 204,000 SNPs obtained were scanned later on in the databases in an attempt to identify the SNPs related to Kaposi's Sarcoma. Results: In the 204,000 SNP screenings, we scrutinized the SNPs that differ in the case of Kaposi's Sarcoma [KS (+) and HIV (+)] on the basis of Control [KS(-) and HIV(-)] and HIV+ [KS(-)], and two SNPs of the ENDRA gene, three SNPs of the ADRA1A gene, six SNPs of the STIM1 gene, four SNPs of the EFNB2 gene, and one SNP of the CD209 gene were found to be different. However, when it comes to all SNPs (all the 204.000 SNPs) screened in terms of allele, it was observed that the AA and BB alleles were lower in the patient with Kaposi's Sarcoma [KS (+) and HIV (+)] compared to other groups and AB alleles were found to be higher than others in the patient with Kaposi's sarcoma [KS] (+) and HIV (+)]. Conclusion: In the microarray study we have conducted, 204,000 SNPs were screened for Control (HIV-) HIV (+) and HIV (+) patient with Kaposi's Sarcoma. It was found that 32,362 of those SNPs had different alleles in the Kaposi's Sarcoma [KS + HIV (+)] patient, while they had the same ones in the control [KS (-) and HIV (-)] and HIV + [KS (-)] group. 16 of the 32,362 SNPs took place among the genes related to Kaposi's Sarcoma. In the cases of Kaposi's Sarcoma with suspected diagnosis, it can be used as a beneficial laboratory test.

APA, Harvard, Vancouver, ISO, and other styles

35

Pergolizzi, Stefano, Anna Santacaterina, Michele Gaeta, and Alfredo Blandino. "Kaposi's Sarcoma in Young Patients Treated with Orthovoltage Irradiation and Having a Minimum Follow-Up of Forty-Six Years." Tumori Journal 95, no. 3 (May 2009): 325–28. http://dx.doi.org/10.1177/030089160909500309.

Full text

Abstract:

Purpose To describe the clinical outcome and to evaluate the role of orthovoltage radiotherapy in the treatment of young (less than 30 years old) Mediterranean men with Kaposi's sarcoma. Patients and methods We reviewed the records of 198 consecutive patients with Kaposi's sarcoma treated with orthovoltage radiation therapy at our department between January 1920 and December 1987. Result We found three young shepherds, aged less than 30 years, with an available follow-up ranging from 45 to 67 years. One patient died at the age of 84 years of chronic renal failure while suffering from cutaneous Kaposi's sarcoma; two patients are still alive with recurrent Kaposi's sarcoma. Conclusions We presume that an indolent form of Kaposi's sarcoma may occur in young men. This very indolent form can be controlled for the duration of the patient's life by judiciously applied radiation therapy.

APA, Harvard, Vancouver, ISO, and other styles

36

Singh, Bhuvanesh, Gady Har-El, and Frank E. Lucente. "Kaposi's Sarcoma of the Head and Neck in Patients with Acquired Immunodeficiency Syndrome." Otolaryngology–Head and Neck Surgery 111, no. 5 (November 1994): 618–24. http://dx.doi.org/10.1177/019459989411100513.

Full text

Abstract:

Kaposi's sarcoma is the most common neoplastic process in patients infected with the human immunodeficiency virus. Moreover, the occurrence of Kaposi's sarcoma in human immunodeficiency virus—infected patients advances their classification to having the acquired immunodeficiency syndrome. We reviewed the medical records of 48 patients with human immunodeficiency virus infection who had Kaposi's sarcoma documented on their initial visit to the hospital. The onset of Kaposi's sarcoma occurred independent of the Centers for Disease Control and Prevention classification of human immunodeficiency virus infection (modified to exclude Kaposi's sarcoma). This neoplasm developed more frequently in patients who acquired human immunodeficiency virus infection by sexual contact (75% of cases), but manifestations were not significantly different in any of the risk populations for human immunodeficiency virus infection. Kaposi's sarcoma lesions were unpredictable and either showed progression, remained static, or occasionally, regressed spontaneously. Moreover, the lesions were usually multifocal at presentation, with the head and neck (62.5% of cases) as the primary site of involvement. In this region cutaneous lesions predominated (66.7%), followed by mucosal (56.7%) and deep structure (13.3%) involvement. The majority of patients with acquired immunodeficiency syndrome Kaposi's sarcoma involving head and neck structures were asymptomatic (80% of cases). Mucosal lesions were associated with symptoms in 29.3% of cases, whereas cutaneous lesions had symptoms in 5% of cases.

APA, Harvard, Vancouver, ISO, and other styles

37

Murthy MS, Cody Lawrence, Todd Brown, and Shanika Sharma. "Presence of Kaposi's Sarcoma and of Behcet’s Disease Concomitantly in a Patient." International Healthcare Research Journal 6, no. 12 (March 12, 2023): RV1—RV3. http://dx.doi.org/10.26440/ihrj/0611.02591.

Full text

Abstract:

Iatrogenic Kaposi’s sarcoma is a subtype of Kaposi’s sarcoma (KS), which is a vascular malignant tumor and is seen in organ transplant recipients and in patients receiving immunosuppressive therapy due to other reasons. We describe a case of Behcet's disease associated with Kaposi's sarcoma occurring simultaneously in a 50-year-old male patient. Colchicine and steroids were administered for his mucocutaneous findings and polyarthritis. In few months on therapy, four symmetric, brown- red coloured, asymptomatic macules developed on the inner surface of his left foot. In histopathologic specimens; CD34 positive, atypical spindle cells with swollen nuclei formed bundles and vascular spaces filled with erythrocytes. The patient was diagnosed as KS clinically and histopathologically. HHV-8 DNA was positive with PCR. Regression was observed in the lesions after the cessation of corticosteroid treatment.

APA, Harvard, Vancouver, ISO, and other styles

38

Moore, Patrick S., and Yuan Chang. "Kaposi's Sarcoma Findings." Science 270, no. 5233 (October 6, 1995): 15. http://dx.doi.org/10.1126/science.270.5233.15.b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Rosen, Ted, Jennifer Hoffman, and Allison Jones. "Penile Kaposi's sarcoma." Journal of the European Academy of Dermatology and Venereology 13, no. 1 (July 1999): 71–73. http://dx.doi.org/10.1111/j.1468-3083.1999.tb00853.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Atassi, Tamer, and Elizabeth Montgomery. "Cecal Kaposi's Sarcoma." New England Journal of Medicine 349, no. 24 (December 11, 2003): 2340. http://dx.doi.org/10.1056/nejmicm010829.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Eisman, S., E. A. O'Toole, C. Collis, and M. H. A. Rustin. "Zosteriform Kaposi's sarcoma." Clinical and Experimental Dermatology 26, no. 5 (July 2001): 402–4. http://dx.doi.org/10.1046/j.1365-2230.2001.00845.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Gallo, R. C. "Kaposi's Sarcoma: Correction." Science 283, no. 5405 (February 19, 1999): 1115g—1115. http://dx.doi.org/10.1126/science.283.5405.1115g.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Joffe, Ellen, and Louis D. Dubilier. "Classic Kaposi's sarcoma." Journal of the American Academy of Physician Assistants 18, no. 7 (July 2005): 44–46. http://dx.doi.org/10.1097/01720610-200507000-00008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Moore, P. S., and Y. Chang. "Kaposi's Sarcoma Findings." Science 270, no. 5233 (October 6, 1995): 15b. http://dx.doi.org/10.1126/science.270.5233.15b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Nguyen, Dung A., Rajinder K. Chitkara, Jon C. Kosek, and Priscilla S. A. Sarinas. "Endobronchial Kaposi's Sarcoma." Journal of Bronchology 9, no. 1 (January 2002): 30–33. http://dx.doi.org/10.1097/00128594-200201000-00010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Schwartz, Robert A. "Cystic Kaposi's sarcoma." Journal of the American Academy of Dermatology 35, no. 2 (August 1996): 247. http://dx.doi.org/10.1016/s0190-9622(96)90341-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Chi, Chien-Hua, and Tzung-Shiahn Sheen. "Oropharyngeal Kaposi's Sarcoma." Otolaryngology–Head and Neck Surgery 124, no. 3 (March 2001): 352. http://dx.doi.org/10.1067/mhn.2001.110862.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Boshoff, Chris. "Kaposi's Sarcoma Biology." IUBMB Life (International Union of Biochemistry and Molecular Biology: Life) 53, no. 4-5 (April 1, 2002): 259–61. http://dx.doi.org/10.1080/15216540212645.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Trindade, AJ, JZ Potack, and V. Parkas. "Gastrointestinal: Kaposi's sarcoma." Journal of Gastroenterology and Hepatology 22, no. 7 (July 2007): 1165. http://dx.doi.org/10.1111/j.1440-1746.2007.05026.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Bashar, Nada, Nicholas Innes, and Julian Orrell. "Bronchopulmonary Kaposi's sarcoma." Respiratory Medicine Case Reports 15 (2015): 45–47. http://dx.doi.org/10.1016/j.rmcr.2015.04.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!